Mind Medicine (MNMD) Price & Analysis

Compare

2,008 Followers

MNMD Stock Chart & Stats

$12.38

-$0.97(-11.96%)

At close: Jan 08 4:00 PM EST

$12.38

-$0.97(-11.96%)

Day’s Range― - ―

52-Week Range$4.70 - $14.30

Previous CloseN/A

Volume779.86K

Average Volume (3M)1.91M

Market Cap

$948.82M

Enterprise Value$412.10M

Total Cash (Recent Filing)$182.99M

Total Debt (Recent Filing)$41.19M

Price to Earnings (P/E)―

Beta1.54

Next Earnings

Nov 12, 2025

EPS Estimate

-0.5

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.50

Shares Outstanding76,087,944

10 Day Avg. Volume2,076,993

30 Day Avg. Volume1,906,010

Financial Highlights & Ratios

PEG Ratio0.12

Price to Book (P/B)2.03

Price to Sales (P/S)0.00

P/FCF Ratio-6.20

Enterprise Value/Market Cap0.43

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda-3.74

Forecast

1Y Price Target

$27.10

Price Target Upside118.90% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering10

Bulls Say, Bears Say

Bulls Say

Financial StabilityMindMed has a robust cash position of $237.9 million, supporting its ongoing development efforts.

Market DifferentiationMindMed continues to frame MM120’s clinical value proposition around infrequent, durable dosing, differentiating the drug from chronic daily therapies.

Strategic PositionBreakthrough Therapy designation granted by the FDA to MM120 in GAD supports the company's strategic position.

Bears Say

Clinical Execution RisksManagement underscored the adaptive blinded sample size re-estimation built into each trial, allowing for a potential increase in enrollment as a de-risking safeguard.

Market PerceptionMNMD is seen as underappreciated in massive markets needing improved treatments.

Mind Medicine News

Psychedelic: Needham initiates coverage of atai, GH Research, MindMed

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

10d ago

ABBV

ATAI

Mind Medicine initiated with an Outperform at LifeSci Capital

LifeSci Capital analyst Francois Brisebois initiated coverage of Mind Medicine (MNMD) with an Outperform rating and $32 price...

12d ago

MNMD

3 Best Stocks to Buy Now, 10/13/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below...

13d ago

INR

Mind Medicine initiated with a Buy at Needham

Needham analyst Ami Fadia initiated coverage of Mind Medicine (MNMD) with a Buy rating and $28 price target...

13d ago

MNMD

MindMed Issues Inducement Grant to New Employee

An announcement from Mind Medicine ( ($MNMD) ) is now available. MindMed announced the issuance of an inducement...

10d ago

MNMD

Mind Medicine’s MM120: Promising Phase 3 Trials and Strategic Growth Potential

Mind Medicine (MNMD) has received a new Buy rating, initiated by Needham analyst, Ami Fadia. Ami Fadia has...

13d ago

MNMD

Psychedelic: Exclusive talk with ibogaine clinic Beond

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Tom Feegel, CEO and co-founder of...

1M ago

ATAI

CMND

MindMed Study Highlights Urgent Need for Suicide Risk Screening in GAD Patients

Mind Medicine ( ($MNMD) ) has issued an announcement. MindMed presented a study at Psych Congress 2025 revealing...

1M ago

MNMD

MindMed Issues Inducement Grants to New Employees

Mind Medicine ( ($MNMD) ) has shared an update. MindMed has announced the issuance of inducement grants to...

1M ago

MNMD

Mind Medicine participates in a conference call with Cantor Fitzgerald

Conference call with management will be held on September 29 at 12 pm hosted by Cantor Fitzgerald.Webcast Link...

1M ago

MNMD

Psychedelic: Exclusive talk with biopharma company MindMed

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Daniel Karlin, Chief Medical Officer at...

1M ago

MNMD

Mind Medicine’s Strategic Focus and Commercial Scalability Drive Buy Rating

In a report released today, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Mind Medicine, with...

1M ago

MNMD

MindMed to Engage in Key September Investor Conferences

Mind Medicine ( ($MNMD) ) just unveiled an update. MindMed has announced its participation in several investor conferences...

2M ago

MNMD

MindMed’s MM120 Shows Promise in Treating Generalized Anxiety Disorder

An update from Mind Medicine ( ($MNMD) ) is now available. Mind Medicine announced that the Journal of...

2M ago

MNMD

MNMD FAQ

What was Mind Medicine Inc.’s price range in the past 12 months?

Mind Medicine Inc. lowest stock price was $4.70 and its highest was $14.30 in the past 12 months.

What is Mind Medicine Inc.’s market cap?

Mind Medicine Inc.’s market cap is $948.82M.

When is Mind Medicine Inc.’s upcoming earnings report date?

Mind Medicine Inc.’s upcoming earnings report date is Nov 12, 2025 which is in 17 days.

How were Mind Medicine Inc.’s earnings last quarter?

Mind Medicine Inc. released its earnings results on Aug 05, 2025. The company reported -$0.5 earnings per share for the quarter, missing the consensus estimate of -$0.38 by -$0.12.

Is Mind Medicine Inc. overvalued?

According to Wall Street analysts Mind Medicine Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Mind Medicine Inc. pay dividends?

Mind Medicine Inc. does not currently pay dividends.

What is Mind Medicine Inc.’s EPS estimate?

Mind Medicine Inc.’s EPS estimate is -0.5.

How many shares outstanding does Mind Medicine Inc. have?

Mind Medicine Inc. has 76,087,944 shares outstanding.

What happened to Mind Medicine Inc.’s price movement after its last earnings report?

Mind Medicine Inc. reported an EPS of -$0.5 in its last earnings report, missing expectations of -$0.38. Following the earnings report the stock price went up 2.593%.

Which hedge fund is a major shareholder of Mind Medicine Inc.?

Currently, no hedge funds are holding shares in MNMD

Mind Medicine Stock Smart Score

Outperform

Fundamentals

Return on Equity

-59.11%

Trailing 12-Months

Asset Growth

-1.14%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Mind Medicine Inc.

Mind Medicine (MNMD), also known as MindMed, is a biotechnology company focused on developing psychedelic-inspired therapies for the treatment of mental health disorders. The company operates in the biopharmaceutical sector, primarily targeting conditions such as anxiety, depression, addiction, and ADHD through innovative drug development. MindMed's core products and services include research and development of novel psychedelic compounds, clinical trials, and collaborations with healthcare professionals to create effective mental health treatments.

Mind Medicine (MNMD) Earnings & Revenues

Historic Earnings Reports

MNMD Stock 12 Month Forecast

Average Price Target

$27.10

▲(118.90% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","17":"$17","30":"$30","43":"$43","56":"$56"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":55,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$55.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27.1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$27.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$16.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,17,30,43,56],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.33,15.612307692307692,18.894615384615385,22.176923076923075,25.45923076923077,28.74153846153846,32.02384615384615,35.30615384615385,38.58846153846154,41.870769230769234,45.153076923076924,48.43538461538461,51.7176923076923,{"y":55,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.33,13.466153846153846,14.602307692307694,15.73846153846154,16.874615384615385,18.01076923076923,19.146923076923077,20.283076923076926,21.419230769230772,22.555384615384618,23.691538461538464,24.82769230769231,25.963846153846156,{"y":27.1,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.33,12.612307692307692,12.894615384615385,13.176923076923076,13.45923076923077,13.741538461538461,14.023846153846154,14.306153846153846,14.588461538461539,14.87076923076923,15.153076923076924,15.435384615384615,15.717692307692307,{"y":16,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.63,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.14,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.14,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.96,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.79,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.72,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.54,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.59,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.48,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.68,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.44,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.13,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.33,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >